小鵬(09868.HK)X9正式在印尼上市 啟動本地化生產
小鵬(09868.HK)公布,全球旗艦純電MPV小鵬X9正式在印尼上市,起售價9.9億印尼盾(約48萬港元)。另外,右舵版小鵬X9將於今年7月在雅加達當地投產,標誌著小鵬汽車首個海外本地化生產項目在印尼即將正式啟動。
小鵬印尼基地瞄準東南亞最大的汽車市場。印尼不僅是該地區人口最多的國家,也是年銷售潛力達百萬輛的核心市場。本土化生產將提升當地市場響應效率,為印尼及周邊區域提供更定制化的智能電動解決方案,加速技術普及與應用。
小鵬汽車董事長CEO何小鵬稱,小鵬X9有信心在2025年登頂亞太高端純電MPV銷量冠軍。截止今年6月,小鵬已進入全球40多個國家和地區。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.